Get the Stockscreener App
0.9631
0.95%
0.0091
Neuronetics Inc stock is traded at $0.9631, with a volume of 173.70K.
It is up +0.95% in the last 24 hours and down -2.72% over the past month.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
See More
Previous Close:
$0.954
Open:
$0.95
24h Volume:
173.70K
Relative Volume:
0.40
Market Cap:
$28.44M
Revenue:
$69.23M
Net Income/Loss:
$-33.10M
P/E Ratio:
-0.8523
EPS:
-1.13
Net Cash Flow:
$-39.26M
1W Performance:
+20.01%
1M Performance:
-2.72%
6M Performance:
-55.82%
1Y Performance:
-32.18%
1-Day Range:
$0.92
$0.9808
1-Week Range:
$0.76
$1.04
52-Week Range:
$0.52
$5.0699
Neuronetics Inc Stock (STIM) Company Profile
Name
Neuronetics Inc
Sector
Industry
Phone
877-600-7555
Address
3222 PHOENIXVILLE PIKE, MALVERN, PA
Compare STIM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
0.9631 | 28.44M | 69.23M | -33.10M | -39.26M | -1.13 |
|
TMO
Thermo Fisher Scientific Inc
|
521.66 | 199.82B | 42.37B | 6.14B | 7.78B | 15.26 |
|
DHR
Danaher Corp
|
238.83 | 173.66B | 23.74B | 3.89B | 4.98B | 7.93 |
|
A
Agilent Technologies Inc
|
138.14 | 38.64B | 6.51B | 1.29B | 1.37B | 3.82 |
|
IQV
Iqvia Holdings Inc
|
201.43 | 36.52B | 15.32B | 1.41B | 1.96B | 5.95 |
|
IDXX
Idexx Laboratories Inc
|
421.76 | 34.55B | 3.84B | 866.24M | 792.60M | 9.80 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-13-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-13-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-13-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jan-22-21 | Upgrade | William Blair | Mkt Perform → Outperform |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jul-24-18 | Initiated | Canaccord Genuity | Buy |
View All
Neuronetics Inc Stock (STIM) Latest News
Transcranial Magnetic Stimulator Market Overall Study Report - openPR
GSA Capital Partners LLP Purchases 30,837 Shares of Neuronetics, Inc. (NASDAQ:STIM) - Defense World
Transcranial Magnetic Stimulator Market Future Business - openPR
FDA Clears NeuroStar's TMS Therapy for Adolescents with Major Depressive Disorder - MSN
Neuronetics to Showcase Neurohealth Innovations at Piper Sandler Healthcare Conference! - MSN
Greenbrook TMS Strategic Acquisition and Restructuring by Neuronetics - TipRanks
Neuronetics Announces Q3 2024 Financial Results and Greenbrook TMS Acquisition Approval - MSN
Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference - The Manila Times
Neuronetics to Present at Piper Sandler Healthcare Conference in December 2024 | STIM Stock News - StockTitan
Neuronetics Grants Inducement Awards to New Employees - MSN
Neuronetics Expands TMS Coverage, Enhancing Access for MDD Treatment - MSN
Neuronetics, Inc. (NASDAQ:STIM) Analysts Just Slashed Next Year's Revenue Estimates By 12% - Simply Wall St
Neuronetics Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
Need To Know: The Consensus Just Cut Its Neuronetics, Inc. (NASDAQ:STIM) Estimates For 2025 - Yahoo Finance
William Blair Decreases Earnings Estimates for Neuronetics - Defense World
Greenbrook TMS Acquisition by Neuronetics Approved - TipRanks
Neuronetics, Inc. (NASDAQ:STIM) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Yahoo Finance
Neuronetics regains Nasdaq compliance with bid price By Investing.com - Investing.com Australia
CANNELL CAPITAL LLC Adjusts Stake in Neuronetics Inc - GuruFocus.com
Neuronetics Inc. (STIM) Quarterly 10-Q Report - Quartzy
Neuronetics (STIM) Reports Q3 Loss, Lags Revenue Estimates - MSN
Earnings call: Neuronetics reports revenue growth amidst strategic shifts By Investing.com - Investing.com Nigeria
Neuronetics regains Nasdaq compliance with bid price - Investing.com
Earnings call: Neuronetics reports revenue growth amidst strategic shifts - Investing.com
Neuronetics, Inc. (NASDAQ:STIM) Q3 2024 Earnings Call Transcript - Insider Monkey
Neuronetics announces inducement grant - Medical Buyer
Neuronetics Regains Nasdaq Compliance with Bid Price - TipRanks
Neuronetics stock hits 52-week low at $0.66 amid market challenges - Investing.com Australia
Neuronetics Inc (STIM) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Rising Expenses and Strategic Shifts - GuruFocus.com
Neuronetics, Inc. Holds Special Meeting of Stockholders and Receives Approval for Various ProposalsNeuronetics, Inc. (NASDAQ: STIM) recently conducted a Special Meeting of Stockholders on November 8, 2024, whereby several proposals were put forth fo - Defense World
Neuronetics (NASDAQ: STIM) Announces Key Financial Updates and FDA Clearance for Adolescent Treatment - Defense World
Neuronetics Inc (STIM) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Rising Expenses ... - Yahoo Finance
Neuronetics Reports Growth and Strategic Acquisition - TipRanks
CORRECTION-Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results - The Manila Times
Neuronetics Q3 Revenue Grows 4%, Margins Surge Despite Widening Losses | STIM Stock | STIM Stock News - StockTitan
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Neuronetics Awards 13,500 RSUs to New Employees in Key Talent Acquisition Move | STIM Stock News - StockTitan
500: Something went wrong - Investing.com India
U.S. Stock market: BTC Digital(+314.68%), BTCS Inc.(+35.64%), Neuronetics(−41.36%) among most volatile stocks during mid day trading - Business Upturn
Neuronetics Inc (STIM) Q3 2024 Earnings: EPS of $(0.44) Misses E - GuruFocus.com
U.S. Stock market most volatile stocks: Neuronetics(-47.27%), Heron Therapeutics(-20.15%) and LogicMark(+94.36%) in early trading - Business Upturn
Neuronetics: Q3 Earnings Snapshot - San Antonio Express-News
Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results - The Manila Times
Neuronetics Q3 Revenue Grows 4% to $18.5M, Margins Surge Despite Wider Losses | STIM Stock News - StockTitan
Greenbrook TMS Shareholders Approve Neuronetics Acquisition - TipRanks
Neuronetics Inc (STIM) Q3 2024 Earnings Report Preview: What to Expect - GuruFocus.com
Neuronetics (STIM) Set to Announce Quarterly Earnings on Tuesday - Defense World
A Piece Of The Puzzle Missing From Neuronetics, Inc.'s (NASDAQ:STIM) 28% Share Price Climb - Simply Wall St
Neuronetics Inc Stock (STIM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Neuronetics Inc Stock (STIM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| MACAN WILLIAM ANDREW | EVP, GC, CCO and CS |
Oct 08 '24 |
Sale |
0.82 |
1,541 |
1,264 |
402,792 |
1.43%
0.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):